查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684488

流感診斷全球市場：產業分析、規模、佔有率、成長、趨勢和預測（2025-2032 年）

Influenza Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 237 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

重要考察

  • 流感診斷市場規模：18.033 億美元（2025 年）
  • 預計金額：27.115億美元（2032年）
  • 全球市場成長率：6.00%（2025年至2032年的複合年成長率）

流感診斷市場 - 報告範圍

流感診斷市場專注於開發和推廣用於檢測和識別流感病毒（包括甲型流感、乙型流感和丙型流感）的診斷工具。該市場的發展受到季節性和大流行性流感疫情的增加、對快速準確診斷測試的需求不斷增加以及分子​​和血清學測試技術的進步的推動。為了遏制疾病爆發，對早期和準確檢測的需求日益成長，以及對醫療保健基礎設施的投資不斷增加，進一步推動了市場擴張。

市場成長動力

全球流感診斷市場呈現顯著成長，原因包括全球流感感染負擔增加、對疾病早期發現認知的不斷提高以及診斷技術的進步等多種因素。政府和醫療保健組織更加重視流感監測和防範，進一步鼓勵採用流感診斷測試。此外，對就地檢驗的需求和分子診斷的擴展正在推動市場成長。

市場限制

雖然具有顯著成長的潛力，但市場面臨的挑戰包括分子診斷成本高以及某些地區先進醫療設施的使用有限。快速診斷測試（RIDT）的準確性仍然令人擔憂，因為假陰性結果可能會影響及時治療。監管障礙和診斷試劑套件的嚴格核准程序也可能減緩市場擴張。

市場機會

流感診斷市場提供了巨大的成長機會，包括開發創新的高靈敏度測試解決方案以及將人工智慧整合到診斷平台中。向新興市場的擴張和對就地檢驗解決方案的投資可能會提高市場滲透率。此外，診斷製造商和醫療保健提供者之間的策略合作可以提高產品的可近性和可得性，進一步刺激市場需求。

本報告研究了全球流感診斷市場，並對市場動態進行了詳細分析，包括成長動力、趨勢、機會和挑戰。

目錄

第1章執行摘要

第2章 市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含和排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章 關鍵成功因素

  • 產品採用/使用分析
  • 產品賣點/特點
  • 策略與推廣策略
  • 主要法規
  • 疾病流行病學
  • PESTLE分析
  • 波特的分析

第5章 市場背景

  • 宏觀經濟因素
  • 預測因子－相關性和影響力
  • 動態

第6章 新冠疫情危機分析

  • COVID-19 及其影響分析
    • 通過測試
    • 按流感類型
    • 按最終用戶
  • 市場情境（2022 年）

7. 全球流感診斷市場展望（2019-2032）

  • 市場金額表現分析（2019-2024）
  • 當前和未來市場金額預測（2025-2032）
    • 與前一年同期比較趨勢分析
    • 絕對商機分析

8. 全球流感診斷市場前景（按測試） (2019-2032)

  • 簡介/主要發現
  • 市場規模表現分析：按測試（2019-2024）
  • 按測試類型分類的當前和未來市場規模分析和預測（2025-2032）
    • 分子診斷檢測
    • 傳統診斷測試
  • 透過測試分析市場吸引力

9. 流感診斷市場展望（依流感類型分類）（2019-2032 年）

  • 簡介/主要發現
  • 市場規模表現分析：依流感類型（2019-2024）
  • 按流感類型分類的當前和未來市場規模分析和預測（2025-2032 年）
    • 甲型流感
    • 乙型流感
    • 丙型流感
  • 流感類型市場吸引力分析

第 10 章。流感診斷市場展望（按最終用戶分類） (2019-2032)

  • 簡介/主要發現
  • 按最終用戶分類的市場規模績效分析（2019-2024）
  • 按最終用戶分類的當前和未來市場規模分析和預測（2025-2032 年）
    • 醫院
    • 診斷實驗室
    • 研究和學術機構
    • 委外研發機構（CRO）
  • 最終用戶的市場吸引力分析

第 11 章。流感診斷市場按地區展望（2019-2032 年）

  • 介紹
  • 市場規模表現分析：按地區（2019-2024）
  • 現今及未來各地區市場規模分析及預測（2025-2032）
    • 北美洲
    • 拉丁美洲
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東和非洲
  • 按地區分析市場吸引力

12. 北美流感診斷市場展望（2019-2032）

13. 拉丁美洲流感診斷市場展望（2019-2032）

14. 歐洲流感診斷市場展望（2019-2032）

15. 南亞流感診斷市場展望（2019-2032）

第 16 章。東亞流感診斷市場展望（2019-2032 年）

第 17 章。大洋洲流感診斷市場展望（2019-2032 年）

18. 中東和非洲流感診斷市場展望（2019-2032）

第19章市場結構分析

  • 市場分析：依公司層級
  • 主要企業市場佔有率分析
  • 市場集中度
  • 市場影響分析

第20章 競爭分析

  • 競爭儀錶板
  • 衝突詳情
    • Abbott Laboratories
    • Endress+Hauser (Analytik Jena AG)
    • Becton, Dickinson and Company
    • Biocartis
    • bioMerieux Inc
    • Danaher Corporation (Cepheid)
    • F. Hoffmann-La Roche Ltd
    • GenMark Diagnostics, Inc.
    • Luminex Corporation
    • Meridian Bioscience, Inc
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • Hologic

第 21 章 使用的假設與縮寫

第 22 章調查方法

簡介目錄
Product Code: PMRREP13246

Persistence Market Research has recently released a comprehensive report on the global Influenza Diagnostics Market, providing an in-depth analysis of key market dynamics, including driving factors, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, enabling stakeholders to make well-informed decisions.

Key Insights:

  • Influenza Diagnostics Market Size (2025E): USD 1,803.30 Mn
  • Projected Market Value (2032F): USD 2,711.50 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.00%

Influenza Diagnostics Market - Report Scope:

The Influenza Diagnostics Market focuses on the development and adoption of diagnostic tools used to detect and identify influenza viruses, including influenza A, B, and C. The market is driven by the rising prevalence of seasonal and pandemic influenza, increasing demand for rapid and accurate diagnostic tests, and technological advancements in molecular and serological testing. The growing need for early and precise detection to curb disease outbreaks, along with increased investment in healthcare infrastructure, is further fueling market expansion.

Market Growth Drivers:

The global Influenza Diagnostics Market is experiencing significant growth due to multiple factors, including the increasing burden of influenza infections worldwide, rising awareness of early disease detection, and advancements in diagnostic technologies. Governments and healthcare organizations are emphasizing influenza surveillance and preparedness, further driving the adoption of influenza diagnostic tests. Additionally, the demand for point-of-care testing and the expansion of molecular diagnostic methods are propelling market growth.

Market Restraints:

Despite strong growth prospects, the market faces challenges such as high costs associated with molecular diagnostics and limited access to advanced healthcare facilities in certain regions. The accuracy of rapid diagnostic tests (RIDTs) remains a concern, as false-negative results can impact timely treatment. Regulatory hurdles and stringent approval processes for diagnostic kits may also slow market expansion.

Market Opportunities:

The Influenza Diagnostics Market presents substantial growth opportunities, including the development of innovative, high-sensitivity testing solutions and the integration of artificial intelligence (AI) in diagnostic platforms. Expansion into emerging markets and investments in point-of-care testing solutions can drive market penetration. Additionally, strategic collaborations between diagnostic manufacturers and healthcare providers will enhance product accessibility and affordability, further boosting market demand.

Key Questions Answered in the Report:

  • What are the major factors driving global growth in the Influenza Diagnostics Market?
  • How are molecular diagnostic advancements shaping the future of influenza testing?
  • Which diagnostic tests are witnessing the highest adoption rates?
  • Who are the key players in the Influenza Diagnostics Market, and what strategies are they implementing?
  • What are the emerging trends and market projections for influenza diagnostics?

Competitive Intelligence and Business Strategy:

Leading companies in the Influenza Diagnostics Market, such as Abbott Laboratories, Becton, Dickinson and Company, and Thermo Fisher Scientific Inc., are focusing on technological innovations, product launches, and strategic partnerships to strengthen their market presence. Companies are investing in molecular diagnostics, point-of-care testing, and AI-driven diagnostic solutions to enhance influenza detection accuracy and speed. Collaborations with research institutions and healthcare organizations help expand their market footprint and improve accessibility to advanced diagnostic solutions.

Key Companies Profiled:

  • Abbott Laboratories
  • Endress+Hauser (Analytik Jena AG)
  • Becton, Dickinson and Company
  • Biocartis
  • bioMerieux Inc.
  • Danaher Corporation (Cepheid)
  • F. Hoffmann-La Roche Ltd
  • GenMark Diagnostics, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Hologic

Influenza Diagnostics Industry Research by Category:

By Test Type:

  • Molecular Diagnostic Test
  • Traditional Diagnostic Test
  • H1N1 Influenza A Virus Identification Kits
  • Immunoassay Kits
  • Immunofluorescence Antibody Assay

By Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Research & Academic Institutes
  • Contract Research Organizations (CROs)

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic and Promotional Strategies
  • 4.4. Key Regulations
  • 4.5. Disease Epidemiology
  • 4.6. PESTLE Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Market Outlook
    • 5.1.3. Global Infectious Disease Diagnostics Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Influenza Diagnostics Companies & their Historical Growth
    • 5.2.2. Application Innovation in Influenza Diagnostics
    • 5.2.3. Product Adoption Rate
    • 5.2.4. Regulatory Impositions
    • 5.2.5. Growing R&D Investments
    • 5.2.6. Novel Diagnostic Product Development Activities
    • 5.2.7. Awareness Campaigns for Influenza Diagnostics
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Test
    • 6.1.2. By Type of Flu
    • 6.1.3. By End User
  • 6.2. 2022 Market Scenario

7. Global Influenza Diagnostics Market Outlook, 2019-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Influenza Diagnostics Market Outlook, 2019-2032, By Test

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Test, 2019-2024
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test, 2025-2032
    • 8.3.1. Molecular Diagnostics Tests
      • 8.3.1.1. RT-PCR
      • 8.3.1.2. LAMP
      • 8.3.1.3. NASABA
    • 8.3.2. Traditional Diagnostics Tests
      • 8.3.2.1. Rapid Influenza Detection Kits
      • 8.3.2.2. Serological Assays
      • 8.3.2.3. Direct Fluorescent Antibody
      • 8.3.2.4. Viral Culture
      • 8.3.2.5. H1N1 Influenza A Virus Identification Kits
      • 8.3.2.6. Immunoassay Kits
      • 8.3.2.7. Immunofluorescence Antibody Assay
  • 8.4. Market Attractiveness Analysis By Test

9. Global Influenza Diagnostics Market Outlook, 2019-2032, By Type of Flu

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Type of Flu, 2019-2024
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type of Flu, 2025-2032
    • 9.3.1. Type A Flu
    • 9.3.2. Type B Flu
    • 9.3.3. Type C Flu
  • 9.4. Market Attractiveness Analysis By Type of Flu

10. Global Influenza Diagnostics Market Outlook, 2019-2032, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2024
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025-2032
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Laboratories
    • 10.3.3. Research & Academic Institutes
    • 10.3.4. Contract Research Organizations (CRO)
  • 10.4. Market Attractiveness Analysis By End User

11. Global Influenza Diagnostics Market Outlook, 2019-2032, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2024
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2025-2032
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. South Asia
    • 11.3.5. East Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Influenza Diagnostics Market Outlook, 2019 - 2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Test
    • 12.3.3. By Type of Flu
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Test
    • 12.4.3. By Type of Flu
    • 12.4.4. By End User
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. U.S. Influenza Diagnostics Market Analysis
      • 12.5.1.1. Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Test
        • 12.5.1.2.2. By Type of Flu
        • 12.5.1.2.3. By End User
    • 12.5.2. Canada Influenza Diagnostics Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Test
        • 12.5.2.2.2. By Type of Flu
        • 12.5.2.2.3. By End User
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis
  • 12.9. Country Level Analysis & Forecast

13. Latin America Influenza Diagnostics Market Outlook, 2019 - 2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Test
    • 13.3.3. By Type of Flu
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Test
    • 13.4.3. By Type of Flu
    • 13.4.4. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Brazil Influenza Diagnostics Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Test
        • 13.5.1.2.2. By Type of Flu
        • 13.5.1.2.3. By End User
    • 13.5.2. Mexico Influenza Diagnostics Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Test
        • 13.5.2.2.2. By Type of Flu
        • 13.5.2.2.3. By End User
    • 13.5.3. Argentina Influenza Diagnostics Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Test
        • 13.5.3.2.2. By Type of Flu
        • 13.5.3.2.3. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis
  • 13.9. Country Level Analysis & Forecast

14. Europe Influenza Diagnostics Market Outlook, 2019-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. France
      • 14.3.1.3. Italy
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Russia
      • 14.3.1.7. BENELUX
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Test
    • 14.3.3. By Type of Flu
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Test
    • 14.4.3. By Type of Flu
    • 14.4.4. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Germany Influenza Diagnostics Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Test
        • 14.5.1.2.2. By Type of Flu
        • 14.5.1.2.3. By End User
    • 14.5.2. France Influenza Diagnostics Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Test
        • 14.5.2.2.2. By Type of Flu
        • 14.5.2.2.3. By End User
    • 14.5.3. Italy Influenza Diagnostics Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Test
        • 14.5.3.2.2. By Type of Flu
        • 14.5.3.2.3. By End User
    • 14.5.4. U.K. Influenza Diagnostics Market Analysis
      • 14.5.4.1. Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Test
        • 14.5.4.2.2. By Type of Flu
        • 14.5.4.2.3. By End User
    • 14.5.5. Spain Influenza Diagnostics Market Analysis
      • 14.5.5.1. Introduction
      • 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.5.2.1. By Test
        • 14.5.5.2.2. By Type of Flu
        • 14.5.5.2.3. By End User
    • 14.5.6. Russia Influenza Diagnostics Market Analysis
      • 14.5.6.1. Introduction
      • 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.6.2.1. By Test
        • 14.5.6.2.2. By Type of Flu
        • 14.5.6.2.3. By End User
    • 14.5.7. BENELUX Influenza Diagnostics Market Analysis
      • 14.5.7.1. Introduction
      • 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.7.2.1. By Test
        • 14.5.7.2.2. By Type of Flu
        • 14.5.7.2.3. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis
  • 14.9. Country Level Analysis & Forecast

15. South Asia Influenza Diagnostics Market Outlook, 2019 - 2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Test
    • 15.3.3. By Type of Flu
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Test
    • 15.4.3. By Type of Flu
    • 15.4.4. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. India Influenza Diagnostics Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Test
        • 15.5.1.2.2. By Type of Flu
        • 15.5.1.2.3. By End User
    • 15.5.2. Thailand Influenza Diagnostics Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Test
        • 15.5.2.2.2. By Type of Flu
        • 15.5.2.2.3. By End User
    • 15.5.3. Indonesia Influenza Diagnostics Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Test
        • 15.5.3.2.2. By Type of Flu
        • 15.5.3.2.3. By End User
    • 15.5.4. Malaysia Influenza Diagnostics Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Test
        • 15.5.4.2.2. By Type of Flu
        • 15.5.4.2.3. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis
  • 15.9. Country Level Analysis & Forecast

16. East Asia Influenza Diagnostics Market Outlook, 2019 - 2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Test
    • 16.3.3. By Type of Flu
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Test
    • 16.4.3. By Type of Flu
    • 16.4.4. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. China Influenza Diagnostics Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Test
        • 16.5.1.2.2. By Type of Flu
        • 16.5.1.2.3. By End User
    • 16.5.2. Japan Influenza Diagnostics Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Test
        • 16.5.2.2.2. By Type of Flu
        • 16.5.2.2.3. By End User
    • 16.5.3. South Korea Influenza Diagnostics Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Test
        • 16.5.3.2.2. By Type of Flu
        • 16.5.3.2.3. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis
  • 16.9. Country Level Analysis & Forecast

17. Oceania Influenza Diagnostics Market Outlook, 2019-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Test
    • 17.3.3. By Type of Flu
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Test
    • 17.4.3. By Type of Flu
    • 17.4.4. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. Australia Influenza Diagnostics Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Test
        • 17.5.1.2.2. By Type of Flu
        • 17.5.1.2.3. By End User
    • 17.5.2. New Zealand Influenza Diagnostics Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Test
        • 17.5.2.2.2. By Type of Flu
        • 17.5.2.2.3. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis
  • 17.9. Country Level Analysis & Forecast

18. Middle East and Africa Influenza Diagnostics Market Outlook, 2019 - 2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Test
    • 18.3.3. By Type of Flu
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Test
    • 18.4.3. By Type of Flu
    • 18.4.4. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. GCC Countries Influenza Diagnostics Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Test
        • 18.5.1.2.2. By Type of Flu
        • 18.5.1.2.3. By End User
    • 18.5.2. Turkey Influenza Diagnostics Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Test
        • 18.5.2.2.2. By Type of Flu
        • 18.5.2.2.3. By End User
    • 18.5.3. South Africa Influenza Diagnostics Market Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Test
        • 18.5.3.2.2. By Type of Flu
        • 18.5.3.2.3. By End User
    • 18.5.4. North Africa Influenza Diagnostics Market Analysis
      • 18.5.4.1. Introduction
      • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.4.2.1. By Test
        • 18.5.4.2.2. By Type of Flu
        • 18.5.4.2.3. By End User
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Market Trends
  • 18.8. Key Market Participants - Intensity Mapping
  • 18.9. Country Level Analysis & Forecast

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Concentration
  • 19.4. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Deep Dive
    • 20.2.1. Abbott Laboratories
      • 20.2.1.1. Overview
      • 20.2.1.2. Product Portfolio
      • 20.2.1.3. Key Financials
      • 20.2.1.4. Sales Footprint
      • 20.2.1.5. Strategy Overview
        • 20.2.1.5.1. Marketing Strategy
        • 20.2.1.5.2. Product Strategy
        • 20.2.1.5.3. Channel Strategy
    • 20.2.2. Endress+Hauser (Analytik Jena AG)
      • 20.2.2.1. Overview
      • 20.2.2.2. Product Portfolio
      • 20.2.2.3. Key Financials
      • 20.2.2.4. Sales Footprint
      • 20.2.2.5. Strategy Overview
        • 20.2.2.5.1. Marketing Strategy
        • 20.2.2.5.2. Product Strategy
        • 20.2.2.5.3. Channel Strategy
    • 20.2.3. Becton, Dickinson and Company
      • 20.2.3.1. Overview
      • 20.2.3.2. Product Portfolio
      • 20.2.3.3. Key Financials
      • 20.2.3.4. Sales Footprint
      • 20.2.3.5. Strategy Overview
        • 20.2.3.5.1. Marketing Strategy
        • 20.2.3.5.2. Product Strategy
        • 20.2.3.5.3. Channel Strategy
    • 20.2.4. Biocartis
      • 20.2.4.1. Overview
      • 20.2.4.2. Product Portfolio
      • 20.2.4.3. Key Financials
      • 20.2.4.4. Sales Footprint
      • 20.2.4.5. Strategy Overview
        • 20.2.4.5.1. Marketing Strategy
        • 20.2.4.5.2. Product Strategy
        • 20.2.4.5.3. Channel Strategy
    • 20.2.5. bioMerieux Inc
      • 20.2.5.1. Overview
      • 20.2.5.2. Product Portfolio
      • 20.2.5.3. Key Financials
      • 20.2.5.4. Sales Footprint
      • 20.2.5.5. Strategy Overview
        • 20.2.5.5.1. Marketing Strategy
        • 20.2.5.5.2. Product Strategy
        • 20.2.5.5.3. Channel Strategy
    • 20.2.6. Danaher Corporation (Cepheid)
      • 20.2.6.1. Overview
      • 20.2.6.2. Product Portfolio
      • 20.2.6.3. Key Financials
      • 20.2.6.4. Sales Footprint
      • 20.2.6.5. Strategy Overview
        • 20.2.6.5.1. Marketing Strategy
        • 20.2.6.5.2. Product Strategy
        • 20.2.6.5.3. Channel Strategy
    • 20.2.7. F. Hoffmann-La Roche Ltd
      • 20.2.7.1. Overview
      • 20.2.7.2. Product Portfolio
      • 20.2.7.3. Key Financials
      • 20.2.7.4. Sales Footprint
      • 20.2.7.5. Strategy Overview
        • 20.2.7.5.1. Marketing Strategy
        • 20.2.7.5.2. Product Strategy
        • 20.2.7.5.3. Channel Strategy
    • 20.2.8. GenMark Diagnostics, Inc.
      • 20.2.8.1. Overview
      • 20.2.8.2. Product Portfolio
      • 20.2.8.3. Key Financials
      • 20.2.8.4. Sales Footprint
      • 20.2.8.5. Strategy Overview
        • 20.2.8.5.1. Marketing Strategy
        • 20.2.8.5.2. Product Strategy
        • 20.2.8.5.3. Channel Strategy
    • 20.2.9. Luminex Corporation
      • 20.2.9.1. Overview
      • 20.2.9.2. Product Portfolio
      • 20.2.9.3. Key Financials
      • 20.2.9.4. Sales Footprint
      • 20.2.9.5. Strategy Overview
        • 20.2.9.5.1. Marketing Strategy
        • 20.2.9.5.2. Product Strategy
        • 20.2.9.5.3. Channel Strategy
    • 20.2.10. Meridian Bioscience, Inc
      • 20.2.10.1. Overview
      • 20.2.10.2. Product Portfolio
      • 20.2.10.3. Key Financials
      • 20.2.10.4. Sales Footprint
      • 20.2.10.5. Strategy Overview
        • 20.2.10.5.1. Marketing Strategy
        • 20.2.10.5.2. Product Strategy
        • 20.2.10.5.3. Channel Strategy
    • 20.2.11. Quidel Corporation
      • 20.2.11.1. Overview
      • 20.2.11.2. Product Portfolio
      • 20.2.11.3. Key Financials
      • 20.2.11.4. Sales Footprint
      • 20.2.11.5. Strategy Overview
        • 20.2.11.5.1. Marketing Strategy
        • 20.2.11.5.2. Product Strategy
        • 20.2.11.5.3. Channel Strategy
    • 20.2.12. Thermo Fisher Scientific Inc.
      • 20.2.12.1. Overview
      • 20.2.12.2. Product Portfolio
      • 20.2.12.3. Key Financials
      • 20.2.12.4. Sales Footprint
      • 20.2.12.5. Strategy Overview
        • 20.2.12.5.1. Marketing Strategy
        • 20.2.12.5.2. Product Strategy
        • 20.2.12.5.3. Channel Strategy
    • 20.2.13. Hologic
      • 20.2.13.1. Overview
      • 20.2.13.2. Product Portfolio
      • 20.2.13.3. Key Financials
      • 20.2.13.4. Sales Footprint
      • 20.2.13.5. Strategy Overview
        • 20.2.13.5.1. Marketing Strategy
        • 20.2.13.5.2. Product Strategy
        • 20.2.13.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology